Image Courtesy: Getty Images
Scientists have discovered that gene therapy can do more than restore vision in dogs with an inherited eye condition. The treatment also repaired damaged connections between retinal nerve cells, suggesting that the adult retina may retain a greater ability to rebuild itself than previously believed.
The research, led by scientists at Michigan State University, focused on mutations in the CaBP4 gene, which produces a protein essential for communication between cells in the retina. The inherited condition causes severe vision problems in both humans and dogs. The findings, published in Molecular Therapy Advances, point to a potential new approach to treating retinal damage,
Researchers treated affected whippet dogs by injecting their retinas with a harmless virus carrying a functional copy of the CaBP4 gene. The single-dose treatment substantially improved the animals’ vision, particularly in dim lighting, when the missing protein has a significant impact.
However, the most notable discovery involved the physical structure of the retina. Treated areas showed less deterioration, while the outer plexiform layer (OPL), which contains important connections between retinal cells, expanded significantly. Researchers also observed growth and maturation of synaptic ribbons, specialized structures that help transmit visual signals.
These structures normally remain underdeveloped when CaBP4 does not function correctly. The findings indicate that gene therapy may help restore connections that failed to develop properly, rather than simply slowing further damage.
“We were able to show three independent structural changes supporting plasticity in the adult retina,” said veterinary ophthalmologist Billie Beckwith-Cohen of Michigan State University. She added that the treatment repaired existing abnormalities while introducing new structural components.
The researchers compared the genetic mutation to a typo in a construction blueprint. By supplying a working copy of the gene, the therapy effectively provides corrected instructions that allow the retinal system to function more normally.
The improvements persisted during follow-up periods extending to three years, offering encouraging evidence that the structural changes could be long-lasting.
Although the condition is relatively rare, the implications could extend beyond CaBP4-related vision loss. The findings suggest that mature retinal nerve cells may retain the capacity to reorganize and establish functional connections, potentially opening new avenues for treating other neurological conditions.
However, the therapy has not yet been established as an effective treatment for humans. Further research will be needed to determine whether the same structural repair can be achieved safely and consistently in people.
